Get started
Author

Mauro Esteves Hernandes

Observed names: Hernandes, Mauro Esteves, M Hernandes, M.E. Hernandes, MAURO ESTEVES HERNANDES, MAURO HERNANDES, Mauro Esteves Hernandes, Mauro E Hernandes, Mauro E. Hernandes, Mauro Esteves Hernades, Mauro Hernandes
ORCID: 0000-0002-5998-5364
Observed ORCID: 0000-0002-5998-5364
OpenAlex ID: A5007820479
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 3,345
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · Sonia S Anand, Jackie Bosch, et al. · The Lancet · 907
PDF
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · Stuart J Connolly, John W Eikelboom, et al. · The Lancet · 771
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 665
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
2021 · Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, et al. · The Lancet · 502
PDF
The Changing Landscape for Stroke Prevention in AF
2017 · Menno V. Huisman, Kenneth J. Rothman, et al. · Journal of the American College of Cardiology · 285
PDF
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
2019 · Deepak L Bhatt, Philippe Gabriel Steg, et al. · The Lancet · 214
Global Variations in Heart Failure Etiology, Management, and Outcomes
2023 · G-CHF Investigators, Mariela Rasmussen, et al. · JAMA · 208
Mortality and Morbidity in Adults With Rheumatic Heart Disease
2024 · Ganesan Karthikeyan, Mpiko Ntsekhe, et al. · JAMA · 60
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
2022 · Álvaro Avezum, Gustavo B F Oliveira, et al. · The Lancet Regional Health - Americas · 55
PDF
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
2023 · Giulio Francesco Romiti, Bernadette Corica, et al. · EClinicalMedicine · 48
PDF
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
2020 · Kieran F. Docherty, Pardeep S. Jhund, et al. · Diabetes Care · 44
In-Hospital Management and Long-term Clinical Outcomes and Adherence in Patients With Acute Decompensated Heart Failure: Primary Results of the First Brazilian Registry of Heart Failure (BREATHE)
2023 · DENILSON CAMPOS DE ALBUQUERQUE, PEDRO GABRIEL MELO DE BARROS E SILVA, et al. · Journal of Cardiac Failure · 41
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology · 34
PDF
Elevated Troponin Levels after Prolonged Supraventricular Tachycardia in Patient with Normal Coronary Angiography
2006 · Rafael C. Miranda, Maurício N. Machado, et al. · Cardiology · 33
Lesão renal aguda após revascularização do miocárdio com circulação extracorpórea
2009 · Maurício de Nassau Machado, Rafael Carlos Miranda, et al. · Arquivos Brasileiros de Cardiologia · 28
PDF
Effect of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome secondary to community-acquired pneumonia: the STAMINA randomised clinical trial
2024 · Israel Silva Maia, Alexandre Biasi Cavalcanti, et al. · British Journal of Anaesthesia · 20
PDF
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial
2023 · Alvaro Avezum, Haliton Alves Oliveira Junior, et al. · EClinicalMedicine · 19
PDF
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial
2021 · Kieran F. Docherty, Pardeep S. Jhund, et al. · JAMA Cardiology · 19
PDF
Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial
2023 · Luis E. Rohde, Marciane M. Rover, et al. · JAMA Cardiology · 18
Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: An Open-Label, Multicenter Randomized Clinical Trial
2025 · Renato D. Lopes, Edimar Alcides Bocchi, et al. · JAMA · 12
Femoral Versus Radial Access in Primary Angioplasty. Analysis of the ACCEPT Registry
2014 · Pedro Beraldo de Andrade, Mônica Vieira Athanazio de Andrade, et al. · Arquivos Brasileiros de Cardiologia · 10
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
2023 · Wern Yew Ding, Ameenathul Mazaya Fawzy, et al. · Journal of Thrombosis and Thrombolysis · 8
Troponina T positiva em paciente chagásico com taquicardia ventricular sustentada e cinecoronariografia sem lesões obstrutivas
2005 · Maurício de Nassau Machado, Fábio Augusto Suzuki, et al. · Arquivos Brasileiros de Cardiologia · 7
PDF
Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial
2023 · Israel S. Maia, Aline Marcadenti, et al. · The Lancet Regional Health - Americas · 5
Works count: 40
Citation count: 7,381
H-index: 19
I10-index: 22
Year
Topic
Type